ইস্রায়েল - হিব্রু - Ministry of Health

abic ltd. - omeprazole - קפסולות - omeprazole 20 mg - omeprazole - omeprazole - relief of reflux-like symptoms (e.g. heartburn) with frequency of two or more days a week in sufferers aged 18 and over.

ইস্রায়েল - হিব্রু - Ministry of Health

abic ltd. - metformin hydrochloride - קפליות - metformin hydrochloride 850 mg - metformin - metformin - glucophage is indicated in diet-failed, non-insulin dependent diabetic patients, especially if overweight, either alone as initial therapy or in combination with a sulfonylyrea. occasionally, as adjuvant therapy in insulin-dependent diabetic patients particularly who are usually obese and not well controlled with insulin.

ইস্রায়েল - হিব্রু - Ministry of Health

abic ltd. - atenolol - טבליה - atenolol 50 mg - atenolol - atenolol - management of angina pectoris and hypertension, including hypertension of renal origin. late intervention after acute myocardial infarction

ইস্রায়েল - হিব্রু - Ministry of Health

abic marketing ltd, israel - lamivudine as anhydrous; zidovudine - טבליה - zidovudine 300 mg; lamivudine as anhydrous 150 mg - zidovudine - zidovudine - antiretroviral combination therapy for the treatment of hiv infected adults and adolescents over the age of 12 years.

ইস্রায়েল - হিব্রু - Ministry of Health

abic marketing ltd - lamivudine 150 mg - tablets - lamivudine - lamivudine is indicated for use in combination with zidovudine for the treatment of human immunodeficiency virus (hiv) infection when antiretroviral therapy is warranted based on clinical and/or immunological evidence of disease progression.

ইস্রায়েল - হিব্রু - Ministry of Health

abic marketing ltd - lamivudine 300 mg - tablets - lamivudine - lamivudine is indicated for use in combination with zidovudine for the treatment of human immunodeficiency virus (hiv) infection when antiretroviral therapy is warranted based on clinical and/or immunological evidence of disease progression.

ইস্রায়েল - হিব্রু - Ministry of Health

abic marketing ltd, israel - methotrexate - תמיסה להזרקה - methotrexate 25 mg/ml - methotrexate - methotrexate - antineoplastic chemotherapy: treatment of gestational choriocarcinoma, chorioadenoma destruents and hydatidiform mole. palliation of acute lymphocytic leukemia. abitrexate is also indicated in the treatment and prophylaxis of meningeal leukemia. greatest effect has been observed in palliation of acute lymphoblastic (stem cell) leukemias in children. in combination with other anticancer agents, abitrexate may be used for the induction of remission, but is most commonly used in maintenance of induced remissions. abitrexate may be used alone or in combination with other antineoplastics in the management of breast cancer, epidermoid cancers of the head and neck, lung cancer (particularly squamous cell and small cell types), bladder cancer and osteogenic cancer. abitrexate is effective in the treatment of the advanced stages (iii and iv peter's staging system) of lymphosarcoma, particularly in children, and in advanced cases of mycosis fungoides. psoriasis: because of the high risk attending its use, abitrexate is

ইস্রায়েল - হিব্রু - Ministry of Health

abic marketing ltd, israel - fluorouracil - תמיסה להזרקה - fluorouracil 50 mg/ml - fluorouracil - fluorouracil - palliative management of carcinoma of the colon, rectum, breast, stomach and pancreas, in selected patients considered incurable by surgery or other means. as leucovorin-fluorouracil chemotherapy combination for cancer treatment.

ইস্রায়েল - হিব্রু - Ministry of Health

abic marketing ltd - gemcitabine as hydrochloride 200 mg - powder for solution for infusion - gemcitabine - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer.gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage.breast cancer:gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy.prior chemotherapy should have included an anthracycline unless clinically contraindicated.ovarian cancer:gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.

ইস্রায়েল - হিব্রু - Ministry of Health

abic marketing ltd - gemcitabine as hydrochloride 2000 mg - powder for solution for infusion - gemcitabine - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy.prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.